Table 3.
Multivariate analysis of progression-free survival
Prognostic factor
|
HR (95%CI)
|
P value
|
Age | 1.059 (1.033-1.085) | ≤ 0.001 |
ISS stage | 2.136 (1.500-3.041) | ≤ 0.001 |
DS stage | 1.622 (0.264-1.622) | 0.264 |
GPT | 1.017 (0.997-1.036) | 0.097 |
GOT | 1.002 (0.977-1.028) | 0.857 |
LDH | 1.000 (0.997-1.003) | 0.944 |
Platelet count | 1.880 (0.732-4.830) | 0.189 |
Maintenance regimen | 0.410 (0.236-0.710) | 0.001 |
Autotransplantation | 0.201 (0.069-0.583) | 0.003 |
TC | 0.689 (0.533-0.891) | 0.005 |
C1 reduction rate | 0.474 (0.293-0.767) | 0.002 |
C2 reduction rate | 0.792 (0.440-1.427) | 0.438 |
C3 reduction rate | 1.974 (0.921-4.230) | 0.08 |
C4 reduction rate | 0.254 (0.139-0.463) | ≤ 0.001 |
HR: Hazard ratio; 95%CI: 95% confidence interval; ISS: International Staging System; DS: Durie-Salmon; GPT: Glutamic-pyruvic transaminase; GOT: Glutamic-oxaloacetic transaminase; LDH: Lactate dehydrogenase; TC: Total cholesterol; C1: The first cycle; C2: The second cycle; C3: The third cycle; C4: The fourth cycle.